Phibro Animal Health's Shares Rise 25.3% on Updated 2026 Guidance

Phibro Animal Health reported Q2 2026 results with sales of $373.91 million and net income of $27.46 million. The company reaffirmed its quarterly dividend of $0.12 per share and issued full-year 2026 guidance calling for $1.45 billion to $1.50 billion in net sales and diluted EPS of $2.08 to $2.32. The updated guidance has improved the earnings narrative, but leverage and debt coverage remain key watchpoints.